Search

everythinglearnresearchcommunity

for

Search:↓

Cyproterone acetate-estrogen most effective for hirsutism, but consider side effects and patient needs.

Spironolactone effectively reduces hair growth in women with hirsutism and is generally well-tolerated.

Hormonal treatments can help with acne but are not the first choice due to side effects and the need for careful patient selection.

Diane 35 plus finasteride is more effective for treating hirsutism.

Diane 35 plus finasteride is more effective in reducing hair growth and androgen levels, but may decrease libido.

Spironolactone reduces the enzyme activity that converts testosterone to DHT, helping treat excessive hair growth in women.

Male hormones, or androgens, affect women's health in areas like mood and bone density, and hormone replacement therapy using antiandrogenic progestogens can improve mood disorders and alertness in menopausal women.

Treat genetic hair loss early with FDA-approved medications and consider hair transplantation.

Low-dose flutamide helps reduce excessive hair growth and is even more effective with birth control, without bad effects on blood fats.

Treat scalp and beard fungal infections early with oral antifungal medication and sometimes topical therapy, avoiding unnecessary allergy tests and surgery.

Hormonal treatments are effective as a second-line option for moderate-to-severe acne in females, but should be used with caution due to health risks.

Birth control pills and cyproterone acetate can help treat acne in women, especially when linked to hormonal issues.

Blocking the androgen receptor in skin cells reduces their growth response to male hormones, suggesting a possible treatment for skin conditions linked to androgens.

Finasteride reduces hirsutism effectively with fewer side effects but is a second-choice treatment due to safety concerns.

Antiandrogens are effective for conditions like prostate cancer and skin issues, but more research is needed to confirm their benefits and minimize side effects.

All treatments reduce hair growth; low dose flutamide most effective with fewer side effects.

Minoxidil stops cells from making prostacyclin, which may help with hair growth. More research is needed.

Flutamide, an antiandrogen, has minimal impact on female rat endocrine systems and does not significantly change their reproductive cycles.

After severe COVID-19, 71% of patients experienced excessive hair shedding and thinning within 3 months due to factors like low oxygen levels, medication, stress, and autoimmune disease.

The combined therapy improved symptoms in PCOS patients.

A Miniature Pinscher dog with hair loss and scaling was diagnosed with pattern alopecia and improved with melatonin treatment.

Men with liver cancer have higher levels of a specific testosterone byproduct in their liver and blood, despite overall lower male hormone levels.

COVID-19 leaves 80% of patients with long-term symptoms like fatigue and headaches.

Many COVID-19 survivors experience long-term symptoms but still report satisfactory quality of life and return to work.

The European Society of Endocrinology advises individualized long-term management for PCOS, focusing on lifestyle changes, accurate diagnosis, and treatments for associated health risks and symptoms.

Experts recommend using evidence-based methods to diagnose and treat hirsutism, focusing on symptoms and underlying causes.

Stem cell-derived conditioned medium shows promise for treating various medical conditions but requires standardized production and further validation.

The document concludes that the fast-growing direct-to-consumer genetic testing market lacks sufficient regulation, posing risks to consumers due to questionable test quality and accuracy.

Low iron and L-lysine levels can cause hair loss in women, and increasing these nutrients can reduce hair shedding.

Iron deficiency may be related to hair loss, but there's not enough evidence to recommend iron screening or supplements for all hair loss patients.